Cellbae Pte Ltd is an innovative in vitro diagnostic company headquartered in Singapore. It is a spin-off company from the Agency for Science, Technology and Research (A*STAR), Singapore. Cellbae actively develops high-quality diagnostic assays and kits essential for the detection and surveillance of infectious diseases and food pathogens. Our current flagship product is the TEPAT 1.0 SARS-CoV-2 Multiplex RT-PCR Kit for the detection of COVID-19. Cellbae also provides novel predictive toxicology assays for testing the safety of drugs, chemicals, food and consumer care products, and for environmental monitoring.
Improving lives through scientific discovery and technological innovations.
Develop high-quality research reagents and diagnostic tools essential for the detection and surveillance of human and veterinary diseases, as well as food pathogens.